Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Multi-center, Phase 2 Trial to Evaluate the Efficacy and Safety of Candesartan/Amlodipine Combined or Alone and Select Better Dose of CKD-330 in Patients With Essential Hypertension
Conditions
Interventions
Candesartan 8mg
Candesartan 16mg
+2 more
Locations
1
South Korea
Seoul National University Bundang Hospital
Seongnam, South Korea
Start Date
March 1, 2014
Primary Completion Date
April 1, 2015
Completion Date
June 1, 2015
Last Updated
March 30, 2015
NCT06823947
NCT06604897
NCT07448506
NCT07433790
NCT07421414
NCT07421401
Lead Sponsor
Chong Kun Dang Pharmaceutical
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions